Investigating how neuropeptides influence the development of myelin in the nervous system
Neuropeptides as axonal determinants for oligodendrocyte differentiation and myelination
This study is looking at how certain signals from nerve cells, called dynorphins, help the development of cells that create myelin, which is important for proper nerve function in the brain and spinal cord.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10990508 on NIH RePORTER |
What this research studies
This research explores how specific signals from axons, particularly a class of neuropeptides called dynorphins, affect the differentiation of oligodendrocytes and the process of myelination in the central nervous system. By examining the relationship between neuronal activity and the release of these neuropeptides, the study aims to understand how they may promote the maturation of oligodendrocytes, which are crucial for the formation of myelin. The research employs various methodologies to analyze gene expression and the effects of these neuropeptides on cell behavior and differentiation.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who may be experiencing conditions related to myelin dysfunction or acute stress.
Not a fit: Patients with conditions unrelated to myelin formation or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for conditions involving myelin damage, such as multiple sclerosis.
How similar studies have performed: While the specific focus on dynorphins is novel, previous research has shown success in understanding the role of neuropeptides in neural development and myelination.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Chan, Jonah R — University of California, San Francisco
- Study coordinator: Chan, Jonah R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.